Lumos Pharma (NASDAQ:LUMO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Lumos Pharma (LUMO) operate in?

Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Lumos Pharma Stock (NASDAQ: LUMO) stock price, news, charts, stock research, profile.

Open	$3.79
Close	$3.92
Volume / Avg.	29.19K / 78.25K
Day Range	$3.78 - $3.99
52 Wk Range	1.37 - 4.55
Market Cap	$32.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	5.39%
Days to Cover	1.28

Recent News

Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday.

Lisa Levin

Why Is Biomarin & BridgeBio Pharma Rival Lumos Pharma Stock Trading Higher Today?

Lumos Pharma Inc (NASDAQ: LUMO) announced that topline results from its Phase 2 OraGrowtH210 dose-finding trial and its Phase 2 OraGrowtH212 Pharmacokinetic/Pharmacodynamic (PK/PD) trial met all primary

Vandana Singh

Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.79
Close	$3.92
Volume / Avg.	29.19K / 78.25K
Day Range	$3.78 - $3.99
52 Wk Range	1.37 - 4.55
Market Cap	$32.47M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	5.39%
Days to Cover	1.28

About Lumos Pharma Inc

Sector

Health Care

Industry

Biotechnology

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare disease...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lumos Pharma (LUMO) stock?

You can purchase shares of Lumos Pharma (NASDAQ:LUMO) through any online brokerage.

View our list of the best stock brokerages

Who are Lumos Pharma (LUMO) competitors?

Other companies in Lumos Pharma’s space includes: Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS) and Aligos Therapeutics (NASDAQ:ALGS).

What is the forecast, or price target, for Lumos Pharma (LUMO) stock?

Lumos Pharma has a consensus price target of $14.80.

What is the current price for Lumos Pharma (LUMO)?

The stock price for Lumos Pharma (NASDAQ: LUMO) is $4 last updated September 24, 2024 at 7:34 AM EDT.

Does Lumos Pharma (LUMO) pay a dividend?

There are no upcoming dividends for Lumos Pharma.

When is Lumos Pharma (NASDAQ:LUMO) reporting earnings?

Lumos Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Lumos Pharma (LUMO) going to split?

There is no upcoming split for Lumos Pharma.

What sector and industry does Lumos Pharma (LUMO) operate in?

Lumos Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge